Common use of SPONSOR Review Clause in Contracts

SPONSOR Review. Unless otherwise specified in the applicable SOW, the Institution and the Principal Investigator shall submit a copy of any proposed manuscript, abstract, presentation or other document with respect to a Study, including any Multi-Center Publication of which the Principal Investigator is an author, to SPONSOR for review and comment at least forty-five (45) days prior to its submission for publication or presentation. Institution and/or Principal Investigator shall reasonably consider SPONSOR’s comments on the proposed publication or presentation and shall remove any Confidential Information and correct any inaccurate technical information that may be identified by the SPONSOR in writing. Notwithstanding the foregoing, any analyses performed by the Principal Investigator using the Site Data (or, in the case of a Multi-Center Study, any Multi-Center Study Analyses) or that have been disclosed in a publication or presentation authorized pursuant to this Section 18 or pursuant to another clinical study agreement under the Study, shall not be deemed Confidential Information for purposes of this Section 18. If requested in writing by SPONSOR, the Institution and the Principal Investigator shall withhold material from submission for publication or presentation for an additional sixty (60) days to allow for the filing of a patent application or the taking of other measures to establish and preserve SPONSOR’s proprietary rights. Notwithstanding the foregoing, in no event shall Institution or Principal Investigator be required to delay a submission for publication or presentation for more than one hundred twenty (120) days after first submission of a complete publication or presentation to SPONSOR for review. Institution agrees to submit such publication in form that allows SPONSOR to conduct a review sufficient to remove any Confidential Information, correct any inaccurate technical information, and determine if delay is necessary to pursue submission of a patent application. Unless otherwise agreed to in the body of an SOW, to the extent that any provision of this Section 18 may be inconsistent in any respect with any statements about publication policy set forth in a Protocol, the provisions of this Section 18 shall control.

SPONSOR Review. Unless otherwise specified in the applicable SOW, the Institution and the Principal Investigator shall submit a copy of any proposed manuscript, abstract, presentation or other document with respect to a Study, including any Multi-Center Publication of which the Principal Investigator is an author, to SPONSOR for review and comment at least forty-five (45) days prior to its submission for publication or presentation. Institution and/or Principal Investigator shall reasonably consider SPONSOR’s comments on the proposed publication or presentation and shall remove any Confidential Information (other than Study Results) and correct any inaccurate technical information that may be identified by the SPONSOR in writing. Notwithstanding the foregoing, any analyses performed by the Principal Investigator using the Site Data (or, in the case of a Multi-Center Study, any Multi-Center Study Analyses) or that have been disclosed in a publication or presentation authorized pursuant to this Section 18 or pursuant to another clinical study agreement under the Study, shall not be deemed Confidential Information for purposes of this Section 18. If requested in writing by SPONSOR, the Institution and the Principal Investigator shall withhold material from submission for publication or presentation for an additional sixty (60) days to allow for the filing of a patent application or the taking of other measures to establish and preserve SPONSOR’s proprietary rights. Notwithstanding the foregoing, in no event shall Institution or Principal Investigator be required to delay a submission for publication or presentation for more than one hundred twenty (120) days after first submission of a complete publication or presentation to SPONSOR for review. Institution agrees to submit such publication in form that allows SPONSOR to conduct a review sufficient to remove any Confidential InformationInformation (other than Study Results), correct any inaccurate technical information, and determine if delay is necessary to pursue submission of a patent application. Unless otherwise agreed to in the body of an SOW, to the extent that any provision of this Section 18 may be inconsistent in any respect with any statements about publication policy set forth in a Protocol, the provisions of this Section 18 shall control.

SPONSOR Review. Unless otherwise specified in the applicable SOW, the Institution and the Principal Investigator shall submit a copy of any proposed manuscript, abstract, presentation or other document with respect to a StudyTrial, including any Multi-Center Publication of which the Principal Investigator is an author, to SPONSOR for review and comment at least forty-five (45) days prior to its submission for publication or presentation. Institution and/or Principal Investigator shall reasonably consider SPONSOR’s comments on the proposed publication or presentation and shall remove any Confidential Information (other than Trial Results) and correct any inaccurate technical information that may be identified by the SPONSOR in writing. Notwithstanding the foregoing, any analyses performed by the Principal Investigator using the Site Data (or, in the case of a Multi-Center StudyTrial, any Multi-Center Study Trial Analyses) or that have been disclosed in a publication or presentation authorized pursuant to this Section 18 or pursuant to another clinical study Trial agreement under the StudyTrial, shall not be deemed Confidential Information for purposes of this Section 18. If requested in writing by SPONSOR, the Institution and the Principal Investigator shall withhold material from submission for publication or presentation for an additional sixty (60) days to allow for the filing of a patent application or the taking of other measures to establish and preserve SPONSOR’s proprietary rights. Notwithstanding the foregoing, in no event shall Institution or Principal Investigator be required to delay a submission for publication or presentation for more than one hundred twenty (120) days after first submission of a complete publication or presentation to SPONSOR for review. Institution agrees to submit such publication in form that allows SPONSOR to conduct a review sufficient to remove any Confidential InformationInformation (other than Trial Results), correct any inaccurate technical information, and determine if delay is necessary to pursue submission of a patent application. Unless otherwise agreed to in the body of an SOW, to the extent that any provision of this Section 18 may be inconsistent in any respect with any statements about publication policy set forth in a Protocol, the provisions of this Section 18 shall control.

SPONSOR Review. Unless otherwise specified in the applicable SOW, the Institution and the Principal Investigator shall submit a copy of any proposed manuscript, abstract, presentation or other document with respect to a Study, including any Multi-Center Publication of which the Principal Investigator is an author, to SPONSOR for review and comment at least forty-five (45) days prior to its submission for publication or presentation. Institution and/or Principal Investigator shall reasonably consider SPONSOR’s comments on the proposed publication or presentation and shall remove any Confidential Information and correct any inaccurate technical information that may be identified by the SPONSOR in writing. Notwithstanding the foregoing, any analyses performed by the Principal Investigator using the Site Data (or, in the case of a Multi-Center Study, any Multi-Center Study Analyses) or that have been disclosed in a publication or presentation authorized pursuant to this Section 18 or pursuant to another clinical study trial agreement under the Study, shall not be deemed Confidential Information for purposes of this Section 18. If requested in writing by SPONSOR, the Institution and the Principal Investigator shall withhold material from submission for publication or presentation for an additional sixty (60) days to allow for the filing of a patent application or the taking of other measures to establish and preserve SPONSOR’s proprietary rights. Notwithstanding the foregoing, in no event shall Institution or Principal Investigator be required to delay a submission for publication or presentation for more than one hundred twenty (120) days after first submission of a complete publication or presentation to SPONSOR for review. Institution agrees to submit such publication in form that allows SPONSOR to conduct a review sufficient to remove any Confidential Information, correct any inaccurate technical information, and determine if delay is necessary to pursue submission of a patent application. Unless otherwise agreed to in the body of an SOW, to the extent that any provision of this Section 18 may be inconsistent in any respect with any statements about publication policy set forth in a Protocol, the provisions of this Section 18 shall control.